Bulk Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 822221 | IACS-13909 | 2160546-07-4 | ≧98.0% |  |
| IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig | ||||
| 822222 | SEP-363856 HCl ( SEP-856 ) | 1310422-41-3 (HCl) | ≧98.0% | .png) |
| SEP-363856 is a novel trace amine receptor 1 (TAAR1) agonist with serotonin 5-HT1A ac | ||||
| 171553 | Anle138b | 882697-00-9 | ≧98.0% |  |
| Anle138b is an oral, brain-penetrant, general inhibitor of protein aggregation. It wa | ||||
| 171462 | MRTX0902 | 2654743-22-1 | ≧98.0% |  |
| MRTX0902is a potent SOS1 inhibitor which can be used for the therapeutic intervention | ||||
| 122622 | CNS004 | 695205-24-4 | ≧98.0% |  |
| CNS004 is a novel compound that potentiates NMDA receptor currents based on glutamate | ||||
| 232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% | _1883299-62-4.png) |
| Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 | ||||
| 20460 | Ro5-3335 | 30195-30-3 | ≧98.0% |  |
| Ro5-3335 is a lipophilic small molecule RUNX1 inhibitor. | ||||
| 230401 | Glycerol phenylbutyrate ( HPN-100 ) | 611168-24-2 | ≧98.0% | .png) |
| Glycerol phenylbutyrate, also known as HPN-100, is under trials in the treatment of c | ||||
| 24002 | Tert-butyl 6,11-dioxo-6,11-dihydro-5H-benzo[b]carbazole-2-carboxylate | 3024657-88-0 | ≧96.0% |  |
| Tert-butyl 6,11-dioxo-6,11-dihydro-5H-benzo[b]carbazole-2-carboxylate, CAS 3024657-88 | ||||
| 24056 | proTAME | 1362911-19-0 | ≧95.0%+ |  |
| ProTAME is Small molecule inhibitors of the APC/C. | ||||